Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2026-08-20 17:25:46 ET · period of report 2026-08-18 · accession 0001242615-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 17:25 | 2026-08-18 | ARWR | OLUKOTUN ADEOYE Y | Dir | S - Sale | $86.96 | -2,000 | 31.6K | -6% | -$173.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-18 | S | D | 2,000 | $86.96 | 31,600 | D | — | — | (F1) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions. |